Assignee
BIONTECH RNA PHARMACEUTICALS GMBH
DE·21 granted patents·9 pending applications·91 citations·filing 2013–2021
Top patents by PatentIndex Score
30 records- 0197US10808242B2Method for reducing immunogenicity of RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Oct 20, 2020·11 cites·7 claims
- 0293US10717982B2Stabilization of poly(A) sequence encoding DNA sequencesBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2015·Granted Jul 21, 2020·18 cites·19 claims
- 0391US10576146B2Particles comprising a shell with RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted Mar 3, 2020·13 cites·15 claims
- 0490US10155031B2Individualized vaccines for cancerBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2013·Granted Dec 18, 2018·12 cites·19 claims
- 0589US10485884B2RNA formulation for immunotherapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2013·Granted Nov 26, 2019·16 cites·39 claims
- 0687US11045418B2Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Jun 29, 2021·3 cites·8 claims
- 0787US10669322B2RNA molecules encoding cytokine fusion proteins and methods of use thereofBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Jun 2, 2020·4 cites·28 claims
- 0886US11173120B2Stable formulations of lipids and liposomesBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2015·Granted Nov 16, 2021·4 cites·54 claims
- 0982US11156617B2Predicting T cell epitopes useful for vaccinationBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Oct 26, 2021·3 cites·21 claims
- 1079US10301368B2Cytokine fusion proteinsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted May 28, 2019·4 cites·22 claims
- 1178US11471522B2Methods and compositions for stimulating immune responseBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted Oct 18, 2022·1 cites·30 claims
- 1277US11318195B2Formulation for administration of RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 1376US11168337B2RNA replicon for versatile and efficient gene expressionBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Granted Nov 9, 2021·1 cites·23 claims
- 1473US11337922B2Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Granted May 24, 2022·0 cites·17 claims
- 1560US12281138B25′-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing RNA, expressing proteins in therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Apr 22, 2025·0 cites·69 claims
- 1660US2022074948A1Predicting t cell epitopes useful for vaccinationBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Application pending·0 cites
- 1759US2021340170A15'-cap compounds and their uses in stabilizing rna, expressing proteins and in therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Application pending·0 cites
- 1858US11920194B2Methods for characterizing loss of antigen presentationBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted Mar 5, 2024·0 cites·23 claims
- 1952US10808019B2Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligandsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Oct 20, 2020·0 cites·21 claims
- 2052US2022062439A1Localized administration of rna molecules for therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 2151US11020477B2RNA vaccinesBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Granted Jun 1, 2021·0 cites·14 claims
- 2248US12522640B2IL2 agonistsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Jan 13, 2026·0 cites·25 claims
- 2347US2019153425A1Methods for Providing Single-Stranded RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 2447US2021290746A1Individualized Vaccines for CancerBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 2546US12291717B2RNA replicon for reprogramming somatic cellsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted May 6, 2025·0 cites·19 claims
- 2645US2021113606A1Treatment using cytokine encoding rnaBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 2743US2020362313A1Method of enhancing rna expression in a cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
- 2842US2019189241A1Selecting Neoepitopes as Disease-Specific Targets for Therapy with Enhanced EfficacyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 2942US2020191798A1Dose determination for immunotherapeutic agentsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 3030US10429392B2Methods and compositions for diagnosis and treatment of cancerBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2015·Granted Oct 1, 2019·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when BIONTECH RNA PHARMACEUTICALS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →